BuzzFeed, Inc.
For the period ended Dec 31, 2025. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 16, 2026
BZFD$0.46-15.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statement of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating activities: | |||
| Net loss | $(57,334) | $(9,928) | $(89,322) |
| Less: net (income) loss from discontinued operations, net of tax | — | (24,028) | 33,610 |
| Net loss from continuing operations | (57,334) | (33,956) | (55,712) |
| Adjustments to reconcile net loss from continuing operations to cash used in operating activities: | |||
| Depreciation and amortization | 15,828 | 19,146 | 20,333 |
| Unrealized gain on foreign currency | (1,225) | (872) | (1,088) |
| Stock-based compensation | 5,820 | 5,531 | 5,282 |
| Change in fair value of warrants | (1,529) | 1,372 | 11 |
| Change in fair value of derivative liability | — | — | (180) |
| Amortization of debt discount and deferred issuance costs | 7,140 | 6,086 | 1,766 |
| Deferred income tax | 88 | (304) | 3,236 |
| Loss (gain) on disposition of assets | 800 | (1,250) | (175) |
| Loss on investment | — | — | 3,500 |
| Provision for doubtful accounts | (356) | (385) | (581) |
| Impairment expense | 30,199 | — | — |
| Noncash lease expense | 17,473 | 18,123 | 20,017 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | 4,419 | 25,816 | 40,568 |
| Prepaid expenses and other current assets and prepaid expenses and other assets | (224) | 6,129 | 6,284 |
| Film costs | (18,525) | (5) | (1,707) |
| Accounts payable | 5,156 | (30,464) | 19,149 |
| Accrued compensation | (3,888) | (474) | (18,257) |
| Accrued expenses, other current liabilities, and other liabilities | (7,393) | 3,288 | (12,619) |
| Lease liabilities | (21,535) | (22,222) | (23,421) |
| Deferred revenue | 6,338 | (1,245) | (7,098) |
| Cash used in operating activities from continuing operations | (18,748) | (5,686) | (692) |
| Cash used in operating activities from discontinued operations | — | (14,993) | (5,411) |
| Cash used in operating activities | (18,748) | (20,679) | (6,103) |
| Investing activities: | |||
| Capital expenditures | (1,958) | (691) | (964) |
| Capitalization of internal-use software | (12,394) | (12,078) | (13,934) |
| Business combinations, net of cash acquired | (233) | — | — |
| Proceeds from sale of assets | 525 | 350 | 175 |
| Cash used in investing activities from continuing operations | (14,060) | (12,419) | (14,723) |
| Cash provided by investing activities from discontinued operations | — | 191,075 | — |
| Cash (used in) provided by investing activities | (14,060) | 178,656 | (14,723) |
| Financing activities: | |||
| Borrowings from Term Loan | 43,975 | — | — |
| Borrowings from film financing arrangements | 13,638 | — | — |
| Proceeds from co-financing arrangements for feature films | 5,089 | — | — |
| Borrowings on revolving credit facility | — | — | 2,128 |
| Payment on Convertible Notes | (30,000) | (120,000) | — |
| Payment of consent solicitation fees | (2,089) | (900) | — |
| Payment of film financing arrangements for feature films | (2,631) | — | — |
| Payment on revolving credit facility | — | (33,837) | (1,796) |
| Payment of early termination fee for revolving credit facility | — | (500) | — |
| Payment of Term Loan's debt issuance costs | (754) | — | — |
| Repurchase of common stock | (3,332) | — | — |
| Proceeds from exercise of stock options | 16 | 1 | 29 |
|---|---|---|---|
| Payment for shares withheld for employee taxes | (224) | (394) | (451) |
| Proceeds from the issuance of common stock in connection with the at-the-market offering, net of issuance costs | (175) | 1,030 | 902 |
| Distributions to noncontrolling interests | (1,923) | — | — |
| Cash provided by (used in) financing activities | 21,590 | (154,600) | 812 |
| Effect of currency translation on cash and cash equivalents | 309 | (366) | (123) |
| Net (decrease) increase in cash and cash equivalents | (10,909) | 3,011 | (20,137) |
| Cash and cash equivalents and restricted cash at beginning of year | 38,648 | 35,637 | 55,774 |
| Cash and cash equivalents and restricted cash at end of year | $27,739 | $38,648 | $35,637 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.